FindTrial
Sign In

Study on Menstrual Health Factors and Egg Quality in Women Undergoing IVF

Artavadushti as Predictive Markers for Oocyte Quality in IVF:A Cross-Sectional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104164
Enrollment
95
Registered
2026-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil Intervention6: Nil: Nil Intervention7: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females undergoing IVF Normal uterine anatomy EndometriosisStage I II PCOS

Exclusion criteria

Exclusion criteria: Known Chromosomal abnormalities Autosomal systemic diseases Severe Endometriosis stage III IV Metabolic disorders affecting ovarian function

Design outcomes

Primary

MeasureTime frame
To evaluate oocyte quality in IVF cycles and determine its correlation with Ayurvedic parameters such as Artava Lakshana, Beeja Dusti and Dosha predominance.Timepoint: From ovum pickup T0 Baseline during ivf cycle—

Secondary

MeasureTime frame
Ovarian response to stimulation fertilization period ,embryo quality & clinical pregnancy outcomeTimepoint: Ovarian response: Day of trigger (HCG administration) Fertilization rate: 16 18 hours post-insemination Embryo quality: Day 3 and/or Day 5 post-fertilization Clinical pregnancy outcome: 6 8 weeks after embryo transfer—

Countries

India

Contacts

Public ContactDr Madhulika D Tiwari

Dr D Y Patil College Of Ayurved & Research Centre, Pimpri, Pune

madhulika.tiwari@dpu.edu.in9021707346

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026